The current pharmacological landscape of tuberculous meningitis: where to next?

Expert Rev Clin Pharmacol. 2016;9(5):625-7. doi: 10.1586/17512433.2016.1155447. Epub 2016 Mar 3.
No abstract available

Publication types

  • Editorial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antitubercular Agents / administration & dosage
  • Antitubercular Agents / therapeutic use*
  • Humans
  • Tuberculosis, Meningeal / drug therapy*
  • Tuberculosis, Meningeal / microbiology*
  • Tuberculosis, Meningeal / pathology

Substances

  • Antitubercular Agents